India to Turkey: Protein Export Trade Route
India has recorded 16 verified shipments of Protein exported to Turkey, representing a combined trade value of $613.8K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $38.4K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 82% of total export value with 3 shipments worth $506.2K USD. On the buying side, BMED INTERNATIONAL BUSINESS COMPANY is the largest importer in Turkey with $506.2K USD in purchases. The top 3 suppliers — CIPLA LIMITED, PANACEA BIOTEC PHARMA LIMITED, GENETEC LIFESCIENCES — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkey Protein corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $613.8K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 82% of all export value, reflecting the consolidated nature of India's protein manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $38.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with protein's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 13.0%, placing it at rank #15 among India's top protein export destinations globally.
On the import side, key buyers of Indian protein in Turkey include BMED INTERNATIONAL BUSINESS COMPANY, BA PHARMA TRADING LTD, BA PHARMA TRADING LTD, and 7 others. BMED INTERNATIONAL BUSINESS COMPANY is the single largest importer with 3 shipments valued at $506.2K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#15
- Annual growth+13.0%
- Demand growth+11.4%
- Regulatory ease71/100
Top 10 Indian Protein Exporters to Turkey
Showing top 10 of 9 Indian suppliers exporting Protein to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $168.7K per shipment | 3 | $506.2K | 82.5% |
| 2 | PANACEA BIOTEC PHARMA LIMITED Avg $44.2K per shipment | 2 | $88.3K | 14.4% |
| 3 | GENETEC LIFESCIENCES Avg $2.1K per shipment | 4 | $8.4K | 1.4% |
| 4 | ALLIED CHEMICALS AND PHARMACEUTICALS PRIVATE LIMIT Avg $3.0K per shipment | 1 | $3.0K | 0.5% |
| 5 | GENEX PHARMA Avg $2.6K per shipment | 1 | $2.6K | 0.4% |
| 6 | ROYAL MEDICAL PRIVATE LIMITED Avg $1.1K per shipment | 2 | $2.2K | 0.4% |
| 7 | AL ROYAL PHARMACEUTICAL PRIVATE LIMITED Avg $1.7K per shipment | 1 | $1.7K | 0.3% |
| 8 | VAMA LIFECARE PRIVATE LIMITED Avg $701 per shipment | 1 | $701 | 0.1% |
| 9 | RMPL PHARMA LLP Avg $642 per shipment | 1 | $642 | 0.1% |
This table shows the top 10 of 9 Indian companies exporting protein to Turkey, ranked by total trade value. The listed exporters are: CIPLA LIMITED, PANACEA BIOTEC PHARMA LIMITED, GENETEC LIFESCIENCES, ALLIED CHEMICALS AND PHARMACEUTICALS PRIVATE LIMIT, GENEX PHARMA, ROYAL MEDICAL PRIVATE LIMITED, AL ROYAL PHARMACEUTICAL PRIVATE LIMITED, VAMA LIFECARE PRIVATE LIMITED, RMPL PHARMA LLP. CIPLA LIMITED is the dominant supplier with 3 shipments worth $506.2K USD, giving it a 82% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Protein Importers in Turkey
Showing top 10 of 10 known buyers in Turkey receiving Protein shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian protein in Turkey include BMED INTERNATIONAL BUSINESS COMPANY, BA PHARMA TRADING LTD, BA PHARMA TRADING LTD,, TO THE ORDER OF, TO THE ORDER OF, among 10 total buyers. The largest importer is BMED INTERNATIONAL BUSINESS COMPANY, accounting for $506.2K USD across 3 shipments — representing 82% of all protein imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BMED INTERNATIONAL BUSINESS COMPANY | 3 | $506.2K | 82.5% |
| 2 | BA PHARMA TRADING LTD | 1 | $44.5K | 7.2% |
| 3 | BA PHARMA TRADING LTD, | 1 | $43.9K | 7.1% |
| 4 | TO THE ORDER OF | 4 | $8.4K | 1.4% |
| 5 | TO THE ORDER OF | 2 | $3.1K | 0.5% |
| 6 | TO THE ORDER OF MANAGER | 1 | $3.0K | 0.5% |
| 7 | DRAN NAKLIYAT ITH IHR SAN VE TIC | 1 | $1.7K | 0.3% |
| 8 | TO THE ORDER OF INVOICE RAISED TO | 1 | $1.7K | 0.3% |
| 9 | AS PER INVOICE | 1 | $701 | 0.1% |
| 10 | TO THE ORDER OF INVOICE | 1 | $642 | 0.1% |
Top 10 Protein Formulations Imported by Turkey
Showing top 10 of 12 product formulations shipped on the India to Turkey Protein route, ranked by trade value
Turkey imports a wide range of protein formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CIPLA PACLITAXEL (PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION(ALBUMIN-BOUND)100MG PER VIAL)[P/S:1X50ML] — accounts for $312.6K USD across 2 shipments. There are 12 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA PACLITAXEL (PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION(ALBUMIN-BOUND)100MG PER VIAL)[P/S:1X50ML] | 2 | $312.6K | 50.9% |
| 2 | CIPLA PACLITAXEL (PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION(ALBUMIN-BOUND),100MG PER VIAL) (1X50 ML) | 1 | $193.6K | 31.5% |
| 3 | PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.901424042A M/D.02/2025 E/D.01/2027. | 1 | $44.5K | 7.2% |
| 4 | PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.901424027A M/D.07/2024 E/D.06/2026. | 1 | $43.9K | 7.1% |
| 5 | HARMLESS PRODUCT FOR HUMAN USE PACLITAXEL 100 MG VIAL (PROTEIN-BOUNDPARTICLES) PHARMACEUTICALS FINISHED PROD | 4 | $8.4K | 1.4% |
| 6 | ALBUREL VIAL E.BOTT.CON:TOTAL PROTEIN.200G/L SODIUM CAPRYLATE.6.65G/L NA+NOT MORE THAN.160MMOL/L K+NOT MORE THAN 2MMOL/LNOS | 1 | $3.0K | 0.5% |
| 7 | HARMLESS LIFE SAVING PHARMACEUTICAL MEDICINE:HUMAN NORMAL ALBUMIN IP 20% TOTAL PROTEIN 50ML/10G (ALBUREL) (SINGLE BOTTLENOS | 1 | $2.6K | 0.4% |
| 8 | PROTEIN BOUND PARTICLES SUSP 100MG TAXONAB INJ B NO 25CPP03 M DT 03 25 E DT 02 27 | 1 | $1.7K | 0.3% |
| 9 | CANZATAX NAB -100MG (VIAL) (PACLITAXEL(PROTEIN-BOUND PARTICLES) FOR INJECTION) | 1 | $1.7K | 0.3% |
| 10 | HARMLESS MEDICINE FOR HUMAN CONSUMPTIONPACLITAXEL (PROTEIN-BOUND PARTICLES) FORINJECTABLE SUSPENSION 100MG BATCH NONOS | 1 | $701 | 0.1% |
Showing top 10 of 12 Protein formulations imported by Turkey on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 6 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's protein exports to Turkey are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, PANACEA BIOTEC PHARMA LIMITED, GENETEC LIFESCIENCES — together account for 98% of total trade value on this route. The average shipment value of $38.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cipla paclitaxel (paclitaxel protein-bound particles for injectable suspension(albumin-bound),100mg per vial) (1x50 ml) and paclitaxel ( protein-bound particles forinjectable suspension 100 mg) b/n.901424042a m/d.02/2025 e/d.01/2027., suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BMED INTERNATIONAL BUSINESS COMPANY is the largest importer with 3 shipments worth $506.2K USD — representing 82% of all protein imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $613.8K
- Avg. Shipment
- $38.4K
- Suppliers
- 9
- Buyers
- 10
- Transit (Sea)
- ~34 days
- Annual Growth
- +13.0%
Other Protein Routes
Unlock the Full India to Turkey Protein Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — India to Turkey Protein Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Protein to Turkey?
The leading Indian exporters of Protein to Turkey are CIPLA LIMITED, PANACEA BIOTEC PHARMA LIMITED, GENETEC LIFESCIENCES. CIPLA LIMITED holds the largest market share at approximately 82% of total trade value on this route.
Q What is the total value of Protein exports from India to Turkey?
India exports Protein to Turkey worth approximately $613.8K USD across 16 recorded shipments. The average value per shipment is $38.4K USD.
Q Which ports does India use to ship Protein to Turkey?
The most active port of origin is SAHAR AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Turkey for Protein?
The average transit time for Protein shipments from India to Turkey is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Turkey Protein trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.0% with demand growth tracking at 11.4%. The route is ranked #15 among India's top Protein export destinations globally.
Q How many suppliers are active on the India to Turkey Protein route?
There are currently 9 active Indian suppliers exporting Protein to Turkey. The market is moderately concentrated with CIPLA LIMITED accounting for 82% of total shipment value.
Q Who are the main importers of Protein from India in Turkey?
The leading importers of Indian Protein in Turkey include BMED INTERNATIONAL BUSINESS COMPANY, BA PHARMA TRADING LTD, BA PHARMA TRADING LTD,, TO THE ORDER OF, TO THE ORDER OF. BMED INTERNATIONAL BUSINESS COMPANY is the largest buyer with 3 shipments worth $506.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Protein.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 10 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists